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Abstract
This chapter discusses four significant items: (1) incidences of abnormal colposcopy in 
healthy women, (2) comparison of its abnormality with histology and (3) cytology, and 
(4) colposcopic findings focused on the lesions in cervical canal to prevent misdiagnosis.
1. The incidence of atypical colposcopic findings (ACF) was 3.6%, whereas that of ab-
normal cytology (≧ASC-US: Atypical Squamous Cells with Undetermined Signifi-
cance) was 1.1%. The former is more frequent than the latter.
2. The incidence of unsatisfactory colposcopic findings (UCF) was high (24.2%). Pap 
smear is more useful in primary screening, if performed satisfactorily.
3. Colposcopy detects squamous intraepithelial lesions (SILs) constantly regardless of 
the severity of lesions. In cytology, it is easier to miss the lower lesions.
4. The incidence of benign reparatory lesion was 61.4% among women (n = 1317) who 
had either abnormal cytology or colposcopy and was 74.6% if cytology is negative. 
We should realize that colposcopic abnormality does not always show neoplastic 
lesions.
5. Main colposcopic abnormalities were the triad of mosaic, punctation, and aceto-white 
epithelium, which appeared admixed in the majority of cases with tendency of lesion 
severity. However, colposcopic abnormal findings in benign lesions are also the triad, 
although the admixed ones are few.
6. The abnormal areas were wider in order of severity of SILs.
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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1. Introduction
Cytological smear taken from the cervix (Pap smear) has been a useful tool for the primary 
screening of the cervix. However, the sensitivity of cytology is not always high to detect 
milder squamous intraepithelial lesions (SILs, i.e., mild and moderate dysplasia) [1, 2]. It is 
clarified that cancer of the cervix originates from human papillomavirus (HPV) infection [3]. 
Accordingly, the introduction of HPV testing has been suggested as the useful strategy for 
screening for this cancer [4, 5]. Therefore, the standard screening method for this type of can-
cer shall be to use Pap smear with a simultaneous or ancillary HPV test as the primary screen-
ing method, and colposcopy shall be reserved for the detailed examination.
Medical institutions in Japan including ours, and Central and Eastern Europe, including 
Hungary, have had a long history of the cancer detection program for the uterine cervix, 
using simultaneous cervical cytology and colposcopy [6, 7]. Therefore, data from the program 
with simultaneous screening with cytology and colposcopy may be a good model for compar-
ing the two methods.
In this chapter, we report the characteristics of colposcopy and cytology based on the colpos-
copy-guided biopsy and discuss three significant items: (1) incidences of unsatisfactory and 
abnormal colposcopic findings in healthy women, (2) comparison of colposcopic abnormality 
with histology, and (3) cytology. In addition, (4) we also show colposcopic photos focusing on 
the lesions localized in the cervical canal, which is easily missed to be detected.
2. Incidences of colposcopic utility and abnormality in healthy women
2.1. Incidences of unsatisfactory colposcopic findings
Cancer of the cervix originates at the squamocolumnar junction (SCJ), where layers of 
squamous cells and columnar cells come into contact with each other. Therefore, the SCJ 
should be visualized on colposcopy, and cellular samples for Pap smear should be correctly 
obtained from the SCJ area when screening is performed. The result of colposcopy is catego-
rized as unsatisfactory colposcopic findings (UCF) if the SCJ is not visible. The incidence of 
UCF was 24.2% in total (n = 1967, Figure 1) and 20.3% in women (n = 1313) with a history 
of vaginal delivery, whereas in women (n = 97) with a history of Cesarean Section (CS) and 
those (n = 557) who had no history of delivery, these were 53.6% and 28.2%, respectively [7].
In other words, at least one out of every four women shows unsatisfactory findings on col-
poscopy. The incidence of UCF was high in the present series, although it has been generally 
considered to a range from 10 to 15%. This may be due to the increasing older age group in the 
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Japanese population. The mean age of the present series was 50.4 ± 12.7. The results  suggest 
that colposcopy is not suitable for primary screening for cervical cancer. In contrast, there 
were no unsatisfactory Pap smear results in this series.
2.2. Abnormal colposcopic findings and comparison of incidences with cytology
The incidence of abnormal findings on colposcopy (ACF), including ACF 1, 2, and 3 was 
3.6% (Figure 1), and those in women who had undergone vaginal delivery and CS were 1.0 
and 2.3%, respectively, whereas that in those who have no history of delivery was 9.8% [7]. 
Therefore, the screening procedure for women who have no history of delivery should be 
performed carefully.
In contrast, the incidence of abnormal Pap smear was 1.1%, including incidences of 0.7% 
(n = 14) for ASC-US, 0.1% (n = 1) for atypical glandular cells (AGC), and 0.3% (n = 6) for low-
grade squamous intraepithelial lesion (LSIL). The incidence of abnormal cytology is reasonable 
for primary screening in Japan.
Note that the incidence of colposcopic abnormality is more frequent than that of cytology.
3. Details of colposcopic abnormality
3.1. Comparison with histology
Abnormal colposcopic findings were compared with histology based on the colposcopy-guided 
regional biopsies. Women who showed abnormal findings with cytology and/or colposcopy 
were 2016 in number among those (n = 12,138) who were screened and registered at the Kitasato 
Gynecologic Tumor Clinic (Table 1) [2]. Incidences of benign reparatory lesion, mild, moderate, 
and severe dysplasia and carcinoma in situ (CIS) were 61.4, 17.1, 7.6, 5.2, and 7.4%, respectively, 
Figure 1. Distribution of colposcopic findings in healthy women (n = 1967) [7].
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among 1317 women who had colposcopy-guided biopsy excluding invasive carcinomas. The 
benign incidence was 74.6% if cytology (n = 865) was negative.
In other words, the majority of histology shows benign lesions, including squamous metapla-
sia, reserve cell proliferation or chronic cervicitis. We should realize that colposcopic abnor-
mality does not always show neoplastic lesions.
3.2. Abnormal colposcopic findings: extent and characters of the findings
Incidences of abnormal colposcopic findings related to mosaic (M), punctation (P), and aceto-
white epithelium (W) are shown in Table 2, and those with benign, mild, moderate, and 
severe dysplasia, CIS, and stage Ia1 were 76.6, 76.6, 80.0, 93.8, and 83.7%, respectively.
Note that the triad of M, P, and W has significant abnormality on the early cervical lesions, 
including the benign lesions.
The extent of occupying lesions on the vaginal portio were compared with individual SILs, 
including mild, moderate, and severe dysplasia, and carcinoma in situ were compared 
(Figure 2), and the incidences of those >3/4 circle on the portio were 11.4, 8.8, 16.7, and 26.6%, 
respectively, whereas those of ≤1/4 were 51.6, 40.5, 26.3, and 16.0%, respectively [1].
The abnormal colposcopic area is wider along with the more severe lesion.
The characteristic abnormal findings of colposcopy were the triad of mosaic (M), punctation 
(P), and aceto-white epithelium (W) (Figure 3). When compared with each of SILs, incidences 
Cytology Histology
Benign* Mild 
dysplasia
Moderate 
dysplasia
Severe 
dysplasia
CIS Others Total No biopsy
NILM 646 (74.6%) 162 (18.7%) 39 (4.5%) 5 (0.6%) 3 (0.3%) 10 (1.2%) 865 (100%) 424
LSIL+HSIL 
(MD2*)
124 (52.8%) 46 (19.6%) 28 (11.9%) 26 (11.1%) 5 (2.1%) 6 (2.6%) 235 (100%) 238
ASC 13 (44.8%) 6 (20.7%) 3 (10.3%) 6 (20.7%) 1 (3.4%) 29 (100%) 29
HSIL(SD3*) 20 (18.5%) 6 (5.6%) 24 (22.2%) 27 (25%) 31 (28.7%) 108 (100%) 8
CIS 4 (10.5%) 3 (7.9%) 4 (10.5%) 1 (2.6%) 26 (68.4%) 38 (100%) 0
SCC 2 (4.8%) 2 (4.8%) 2 (4.8%) 3 (7.1%) 33 (78.6%) 42 (100%) 0
Total 809 (61.4%) 225 (17.1%) 100 (7.6%) 68 (5.2%) 98 (7.4%) 17 (1.3%) 1317 
(100%)
699
Total 2016
Modified with update in cytologic nomination from Kuramoto et al. [2].
*Squamous metaplasia, reserve cell proliferation and chronic cervicitis.
2*MD=moderate dysplasia.
3*SD=severe dysplasia.
Table 1. Histological diagnosis and cytology in cases with either cytologic or colposcopic abnormality.
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of those of single M, P, or W in mild, moderate, and severe dysplasia, and CIS were 56.0, 
54.0, 40.5, and 30.7, whereas those of combined M, P, and W were 33.2, 37.4, 50.0, and 46.4%, 
respectively, and those of M, P, and W + aV were 4.5, 5.6, 7.0, and 19.2%, respectively [1].
Table 2. Variety of colposcopic findings and cervical lesions.
Figure 2. Extent of occupying lesions on abnormality in circle and SILs [1].
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The combined appearance of the triad of MPW with or without atypical vessels (aV) was more 
frequent in the more severe lesions.
3.3. Comparison between colposcopy and cytology
The incidences between abnormal findings of colposcopy (ACF) and cytology (≥ASC) are com-
pared in SILs. The positive incidences of colposcopy in mild (n = 225), moderate (n = 100), and 
severe (n = 68) dysplasia, and CIS (98) were 87.6, 88.0, 95.6, and 99.0%, respectively, whereas 
those of cytology were 28.0, 61.0, 92.6, and 96.9%, respectively (Figure 4) [2]. The later study 
revealed that the negative incidences of mild (n = 337) and moderate (n = 231) dysplasia were 
decreased into 57.5 and 24.2%, respectively (Table 3) [1].
Note that colposcopy finds constantly the early lesions irrespective of severity. In contrast, 
cytology is inferior in detecting less severe lesions of mild or moderate dysplasia.
Figure 4. Comparison of abnormal incidences between colposcopy and cytology in SILs [2].
Figure 3. Abnormal findings in colposcopy and SILs [1].
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The combined use of cytology and colposcopy, however, is a good combination to elevate the 
quality of correct diagnosis. In addition, colposcopy fails rarely to find each of mild, moder-
ate, and severe dysplasia being compared with cytology (Figure 4 and Table 3), the results 
of which show that colposcopy is a good tool for the secondary screening or the detailed 
examination.
4. Materials and methods
4.1. Materials
4.1.1. For Section 2
The subjects were 1967 consecutive women who underwent screening at the Central Clinic of 
the Kanagawa Health Service Association using Pap smear and colposcopy simultaneously 
[7]. The screening programs are based on governmental or company regulations or individual 
application.
4.1.2. For Section 3
The data are from the registry of Tumor Clinic, Department of Gynecology, Kitasato University 
Hospital, where the screening for cervix carcinoma was performed by using simultaneous 
cytology and colposcopy and were analyzed twice at the level of registry numbers (12,138 
and 20,900), at which occasion cases who showed abnormal findings either cytology (≥ASC) 
or colposcopy (≥ACF), excluding invasive carcinoma of the cervix, were 1918 and 2037, 
respectively.
4.2. Methods of cytology and colposcopy
4.2.1. Pap smear
The cell samples were obtained using a cotton tip (Osaki applicator, Osaki Medical Co. Ltd, 
Nagoya, Japan) and CytobrushⓇ plus (Medscand Medical and Cooper Surgical Company, 
Trumbull, USA) rinsed with physiological saline for the vaginal portio and the cervical 
canal, respectively, and the cells from the two samples were separately placed onto two 
slides or each half of a slide, and the tips of the instruments were rotated without making 
Cytology Colposcopy Mild dysplasia (n=337) Moderate dysplasia (n=231) Severe dysplasia (n=200)
≥ASC ACF 130 (38.6%) 171 (74.1%) 176 (88.0%)
NCF 6 (1.8%) 1 (0.4%) 2 (1.0%)
MLM ACF 194 (57.5%) 56 (24.2%) 22 (11.0%)
NCF 7 (2.1%) 3 (1.3%) 0 (0%)
Table 3. Combined effect of cytology and colposcopy [1].
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the cell-free area. The slide samples were immediately placed into 95% ethyl alcohol for 
fixation. Then, the cellular samples were processed using routine Papanicolaou staining 
procedures.
The cytologic diagnosis for Section 2 was based on the Bethesda System for reporting cervical 
cytology [8, 9]. The diagnosis for Section 3 was based on the criteria of the Japan Association 
of Obstetricians and gynecologists (JAOG), which was modified Papanicolaou classification, 
and rearranged according to the Bethesda System.
4.2.2. Colposcopy
The colposcopic diagnosis was based on the IFCPC 2011 colposcopic classification [10]. 
Additionally, normal colposcopic findings (NCF) were divided into two subcategories, NCFI 
and NCFII. Abnormal colposcopic findings (ACF) were divided into three groups, according 
to their sub-groupings for white epithelium (W), punctation (P), and mosaic (M), which were 
divided into three categories, as listed below:
1. NCF
1. NCFI: NCF with a squamocolumnar junction (SCJ) localized outside of the 
 external os.
2. NCFII: NCF with an SCJ localized within the cervical canal that was confirmed by 
opening the canal with forceps.
2.  ACF
1. ACF1: W1, M1, and P1, with which we image squamous metaplasia.
2. ACF2: W2, M2, and P2, with which we image mild or moderate dysplasia.
3. ACF3: W3, M3, and P3, with which we image severe dysplasia or carcinoma in situ.
4. ACF4: atypical vessels (aV) associated with W, M, and P, with which microinva-
sive cancer is suspected.
W was quantitatively subgrouped based on thickness, i.e., color (bluish, pure, or ivory 
white) and surface texture (smooth or coarse). M was based on the presence of a regular or 
irregular vessel network and vessel diameter. P was based on the distance between Ps and 
P shape.
4.2.3. Histology
Colposcopy-guided biopsies, not infrequently multiple, were obtained from the regional 
ACF areas for histological analysis. SILs were classified into four and adopted the crite-
ria of mild dysplasia, moderate dysplasia, severe dysplasia, or carcinoma in situ following 
Japanese custom, and the most significant portion of diagnosis was selected as the diagnosis 
of the case.
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5. Colposcopy focusing on the lesion in cervical canal
1. Acetic acid is inevitable for colposcopy (Figures 5–7).
2. Normal colposcopic findings (NCF) (Figures 8–10).
3. Grading of M, P, and W (Figures 11–13).
4. Illustrations of colposcopic findings are mandatory (Figure 14).
5. Colposcopy-guided “sniping” biopsy taking (Figure 15).
6. Special attention on the lesion in cervical canal (Figures 16–21).
Figure 5. Colposcopic finding before applying acetic acid.
Figure 6. Careful application of 3% acetic acid giving time longer than 30 s is mandatory. A cotton tip being shaped by 
forceps from cotton ball is effective in the cervical canal.
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Figure 8. Squamocolumnar junction (SCJ) without transformation zone.
Figure 7. Aceto-white grade 3 (w3) after acetic acid applied.
Figure 9. Unsatisfactory colposcopic finding (UCF); SCJ is not visible.
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Figure 10. Transformation zone with nabothian follicle.
Figure 11. Punctation, grade 3 (P3).
Figure 12. Aceto-white epithelium, grade 2 (W2).
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Figure 14. Illustration of colposcopic findings with indicating biopsy points.
Figure 13. Punctation, grade 1 (P1) of benign lesion.
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Figure 15. Colposcopy-guided biopsy, being sniped under colposcopic observation.
Figure 16. Combined ACFs with a large lesion.
Figure 17. Careful inspection in the cervical canal using a forceps is mandatory.
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Figure 18. A lesion with W3, localized in the canal.
Figure 19. M2 lesion localized in the canal.
Figure 20. W2 and P2 localized both outside and inside the canal.
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